GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Laurus Labs Ltd (BOM:540222) » Definitions » Gross Profit

Laurus Labs (BOM:540222) Gross Profit : ₹26,084 Mil (TTM As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Laurus Labs Gross Profit?

Laurus Labs's gross profit for the three months ended in Mar. 2024 was ₹7,177 Mil. Laurus Labs's gross profit for the trailing twelve months (TTM) ended in Mar. 2024 was ₹26,084 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Laurus Labs's gross profit for the three months ended in Mar. 2024 was ₹7,177 Mil. Laurus Labs's Revenue for the three months ended in Mar. 2024 was ₹14,397 Mil. Therefore, Laurus Labs's Gross Margin % for the quarter that ended in Mar. 2024 was 49.85%.

Laurus Labs had a gross margin of 49.85% for the quarter that ended in Mar. 2024 => Durable competitive advantage

During the past 11 years, the highest Gross Margin % of Laurus Labs was 54.07%. The lowest was 27.60%. And the median was 46.61%.


Laurus Labs Gross Profit Historical Data

The historical data trend for Laurus Labs's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laurus Labs Gross Profit Chart

Laurus Labs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13,145.80 25,258.50 26,402.20 32,662.30 26,084.10

Laurus Labs Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6,863.20 5,978.70 6,433.70 6,495.10 7,176.60

Competitive Comparison of Laurus Labs's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, Laurus Labs's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Laurus Labs's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Laurus Labs's Gross Profit distribution charts can be found below:

* The bar in red indicates where Laurus Labs's Gross Profit falls into.



Laurus Labs Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Laurus Labs's Gross Profit for the fiscal year that ended in Mar. 2024 is calculated as

Gross Profit (A: Mar. 2024 )=Revenue - Cost of Goods Sold
=50408.3 - 24324.2
=26,084

Laurus Labs's Gross Profit for the quarter that ended in Mar. 2024 is calculated as

Gross Profit (Q: Mar. 2024 )=Revenue - Cost of Goods Sold
=14396.7 - 7220.1
=7,177

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹26,084 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Laurus Labs's Gross Margin % for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=7,177 / 14396.7
=49.85 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Laurus Labs  (BOM:540222) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Laurus Labs had a gross margin of 49.85% for the quarter that ended in Mar. 2024 => Durable competitive advantage


Laurus Labs Gross Profit Related Terms

Thank you for viewing the detailed overview of Laurus Labs's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Laurus Labs (BOM:540222) Business Description

Traded in Other Exchanges
Address
Road No. 7, Banjara Hills, 2nd Floor, Serene Chambers, Hyderabad, TG, IND, 500034
Laurus Labs Ltd is a pharmaceutical company based in India. It provides active pharmaceuticals ingredients (API) including intermediates, Generic Finished dosage forms (FDF) and Contract Research services. The entity develops APIs and intermediates for select, high-growth antiretrovirals, Hepatitis C and Oncology. It also manufactures APIs in other therapeutic areas, such as anti-asthma, ophthalmology, anti-diabetics, cardiovascular, proton pump inhibitors, among others. The company has its business presence in India and Outside India of which it derives a majority of revenue from Outside India. It generates revenue from the sale of API, Intermediates and Formulations, Contract research services and others.

Laurus Labs (BOM:540222) Headlines

No Headlines